It is currently Fri Jul 03, 2015 8:50 am

News News of Campath (Lemtrada, Alemtuzumab)

Site map of Campath (Lemtrada, Alemtuzumab) » Forum : Campath (Lemtrada, Alemtuzumab)

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

Effects of Lemtrada ‘long lasting’ study finds

Longer-term data indicate the effects of Lemtrada are long-lasting in patients with relapsing-remitting multiple sclerosis (RRMS).... Read More - http://www.ms-uk.org/lemtrada
Read more : Effects of Lemtrada ‘long lasting’ study finds | Views : 451 | Replies : 0


Lemtrada ‘a permanent therapy’ claims doctor

Speaking at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis, Indiana, Mr Samuel F. Hunter, MD, PhD, president of the Advanced Neurosciences Institute in Franklin, Tennessee, gave a presentation on outcomes in patients with relapsing multiple sclerosis (MS) treated with Lemtrada (alemtuzumab)......... Read More - http://www.ms-uk.org/lemtrada
Read more : Lemtrada ‘a permanent therapy’ claims doctor | Views : 316 | Replies : 1


Study finds brain atrophy reduces in Lemtrada patients

Genzyme has announced new magnetic resonance imaging (MRI) data from the Lemtrada clinical development program.

In relapsing remitting multiple sclerosis (RRMS) patients treated with Lemtrada in the Phase III pivotal studies, MRI effects observed in the two-year trials were maintained through two additional years in the extension study (years three and four). After the initial two courses of treatment in the pivotal studies, which were given at month zero and at month 12, approximately 70 ...
Read more : Study finds brain atrophy reduces in Lemtrada patients | Views : 424 | Replies : 0


Campath Approval

Read more : Campath Approval | Views : 488 | Replies : 0


Campath and hair loss

Since I started using campath, my hair falls out more and more.
This was 3 years ago and i have been wearing a permanent wig for almost a year, funny thing is it is just on my head.

I cannot find anything related on the internet, can somebody please help or guide me whether or not it is caused by campath?

I have tried everything on the market to get my hair back but nothing ...
Read more : Campath and hair loss | Views : 586 | Replies : 0


Infusion related side effects/allergic reactions.

I finished my first lot of infusions Friday, today is Monday morning.

I am feeling pretty shite. I am tiered, itching, stinging, blotchy (comes and goes), feeling old ms symptoms. I know it is early days, and I think this is expected side effects, but I don't know.
One of the neurologists said it would be though, another one didn't expect it to be too bad.

How long can I expect to feel knocked off ...
Read more : Infusion related side effects/allergic reactions. | Views : 715 | Replies : 2


MS drugs Lemtrada and Aubagio launched in Ireland

Genzyme's plans to grow its multiple sclerosis business in Europe continued with the launch of two new treatments in the Republic of Ireland.

The company, which serves as the biotech arm of French pharma firm Sanofi, today launched the injectable Lemtrada (alemtuzumab) in the country just weeks after oral multiple sclerosis (MS) treatment Aubagio (teriflunomide) hit the market...... Read More - http://www.ms-uk.org/lemtrada
Read more : MS drugs Lemtrada and Aubagio launched in Ireland | Views : 757 | Replies : 3


SMC approves Lemtrada for RRMS within NHS Scotland

Scottish Medicines Consortium approves Lemtrada for RRMS within NHS Scotland

"Scotland has one of the highest rates of multiple sclerosis in the world, and the approval of Lemtrada in Scotland is an important step forward for people with active RRMS who remain in need of new treatment options. MS treatments have come a long way in the past twenty years and the availability of Lemtrada provides an opportunity for neurologists to offer a new therapy ...
Read more : SMC approves Lemtrada for RRMS within NHS Scotland | Views : 2146 | Replies : 0


US FDA accepts MS drug Lemtrada resubmission for review

The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
Read more : US FDA accepts MS drug Lemtrada resubmission for review | Views : 1610 | Replies : 0


Alemtuzumab: Do the benefits outweigh the risks?

Alemtuzumab: Do the benefits outweigh the risks in treating multiple sclerosis? http://www.ms-uk.org/lemtrada
Read more : Alemtuzumab: Do the benefits outweigh the risks? | Views : 1015 | Replies : 0


 

Login  •  Register


Statistics

Total posts 226244 • Total topics 23793 • Total members 15095


Contact us | Terms of Service